Literature DB >> 32417850

Drug researchers pursue new lines of attack against COVID-19.

Charlotte Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32417850     DOI: 10.1038/d41587-020-00013-z

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.

Authors:  Zakir Khan; Yusuf Karataş; Hazir Rahman
Journal:  Adv Ther       Date:  2020-04-29       Impact factor: 3.845

2.  Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.

Authors:  Michelle A Lally; Philip Tsoukas; Christopher W Halladay; Emily O'Neill; Stefan Gravenstein; James L Rudolph
Journal:  J Am Med Dir Assoc       Date:  2020-10-26       Impact factor: 4.669

Review 3.  Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-01-05       Impact factor: 5.270

Review 4.  Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19.

Authors:  Biswanath Dinda; Manikarna Dinda; Subhajit Dinda; Mithun Chakraborty
Journal:  Eur J Med Chem Rep       Date:  2022-08-28

5.  Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.

Authors:  Rajasekaran Mahalingam; Prakash Dharmalingam; Abirami Santhanam; Sivareddy Kotla; Gangarao Davuluri; Harry Karmouty-Quintana; Guha Ashrith; Rajarajan A Thandavarayan
Journal:  J Cell Physiol       Date:  2020-09-17       Impact factor: 6.513

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.